Feedback (LON:FDBK) Reaches New 12-Month Low – Should You Sell?

Shares of Feedback plc (LON:FDBK) hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as GBX 7.50 and last traded at GBX 7.66, with a volume of 177229 shares trading hands. The stock had previously closed at GBX 8.

Feedback Trading Down 2.6%

The firm has a market cap of £3.29 million, a price-to-earnings ratio of -0.48 and a beta of 0.77. The company has a fifty day moving average price of GBX 10.39 and a 200-day moving average price of GBX 10.62.

About Feedback

Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical.

Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.

By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.

Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.